New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

Alere’s PoC HIV Test Prequalified by WHO

The rapid fourth-generation test is now available for public sector procurement in countries where resources are limited.

HIV Combo / Photo: Alere
HIV Combo / Photo: Alere

A PharmaBiz.com article dated July 16th discussed the recent World Health Organization prequalification awarded to Alere for their HIV Combo, a fourth-generation point-of-care test. Second- and third-generation tests only detect antibodies against HIV, which can take up to 3 weeks to appear after infection has occurred. This new test detects both HIV-1/2 antibodies and the HIV-1 p24 antigen, which can appear up to 7.7 days earlier, which increases case findings at a time when individuals are 10x more likely to transmit HIV. According to the article, the Alere HIV Combo is not approved for sale in the US, but Alere Determine HIV-1/2 Ag/Ab Combo is CLIA-waived and available in the US.

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts